{"name":"Implicit Bioscience","slug":"implicit-bioscience","ticker":"","exchange":"","domain":"implicit.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Atibuclimab","genericName":"Atibuclimab","slug":"atibuclimab","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Atibuclimab","genericName":"Atibuclimab","slug":"atibuclimab","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9HblVITDk3SGpuQlAzWEtEQlRMVkc0bkFiV3hxV2c4VmgtRnMwYy1RaWJEUEtZWWg5ZzM4ZE5aaVE4aE5FcG1tMXJhbzV6TUtpLUwzSFA2aVczYUJoY0Fn?oc=5","date":"2025-03-10","type":"pipeline","source":"nature.com","summary":"Exploring a patient-specific in vitro pipeline for stratification and drug response prediction of microglia-based therapeutics - nature.com","headline":"Exploring a patient-specific in vitro pipeline for stratification and drug response prediction of microglia-based therap","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPMFFrZFpmNXUtc0swQUI4Y0Z1ZWcxTnZ5Q3hjV2NzS0hUaG5MRjU1QVl0SThBR2Zyb3JRTUJpd1BveWl3R3VJa2QwODlka1BhRGdZM0pUVlFBSlpCekZBbXp0RVdQRU4zeVU4cGhCallfLVBJTWVRTlB3cGhaOUJLQUNkalpfWjRoRFFoR2d4d0FTNC1lOGJYU1NGVUJ4MWVPdjZQOVRn?oc=5","date":"2024-09-16","type":"trial","source":"BioSpace","summary":"The HEALEY Platform Trial: Quick Failures and New Hope for ALS - BioSpace","headline":"The HEALEY Platform Trial: Quick Failures and New Hope for ALS","sentiment":"negative"},{"url":"https://news.google.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?oc=5","date":"2020-05-07","type":"trial","source":"The Australian","summary":"Trial treatment targets worst cases - The Australian","headline":"Trial treatment targets worst cases","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}